Log In
BCIQ
Print this Print this
 

carteolol/latanoprost (Mikeluna) (OPC-1085EL)

  Manage Alerts
Collapse Summary General Information
Company Otsuka Pharmaceutical Co. Ltd.
DescriptionFixed-dose ophthalmic solution of carteolol 2%, a non-selective beta blocker, and latanoprost 0.005%, a prostaglandin analogue
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentApproved
Standard IndicationGlaucoma
Indication DetailsTreat glaucoma and ocular hypertension
Regulatory Designation
PartnerSenju Pharmaceutical Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

09/14/2016

Undisclosed

0

0

Get a free BioCentury trial today